Colleen Niswender

Colleen is an Associate Professor and the Warren and Senior Director of Molecular Pharmacology for the Warren Center of Neuroscience Drug Discovery at Vanderbilt University. She has been involved in the development of five compounds which have progressed into clinical trials for schizophrenia, Alzheimer’s disease, and Parkinson’s disease. Her scientific goal is to work with teams that successfully launch drugs to impact one or several neurological, neurodevelopmental, or psychiatric diseases.